JP2016527901A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016527901A5 JP2016527901A5 JP2016534802A JP2016534802A JP2016527901A5 JP 2016527901 A5 JP2016527901 A5 JP 2016527901A5 JP 2016534802 A JP2016534802 A JP 2016534802A JP 2016534802 A JP2016534802 A JP 2016534802A JP 2016527901 A5 JP2016527901 A5 JP 2016527901A5
- Authority
- JP
- Japan
- Prior art keywords
- test method
- cells
- mammal
- cancer
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019152467A JP6902577B2 (ja) | 2013-08-12 | 2019-08-23 | 腫瘍成長を増強する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361865092P | 2013-08-12 | 2013-08-12 | |
| US61/865,092 | 2013-08-12 | ||
| USPCT/US2014/017515 | 2014-02-20 | ||
| PCT/US2014/017515 WO2014130741A2 (en) | 2013-02-20 | 2014-02-20 | Nme inhibitors and methods of using nme inhibitors |
| PCT/US2014/050773 WO2015023694A2 (en) | 2013-08-12 | 2014-08-12 | Method for enhancing tumor growth |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019152467A Division JP6902577B2 (ja) | 2013-08-12 | 2019-08-23 | 腫瘍成長を増強する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016527901A JP2016527901A (ja) | 2016-09-15 |
| JP2016527901A5 true JP2016527901A5 (enExample) | 2017-09-28 |
| JP6640086B2 JP6640086B2 (ja) | 2020-02-05 |
Family
ID=52468797
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016534802A Active JP6640086B2 (ja) | 2013-08-12 | 2014-08-12 | 腫瘍成長を増強する方法 |
| JP2019152467A Active JP6902577B2 (ja) | 2013-08-12 | 2019-08-23 | 腫瘍成長を増強する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019152467A Active JP6902577B2 (ja) | 2013-08-12 | 2019-08-23 | 腫瘍成長を増強する方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP4233536B1 (enExample) |
| JP (2) | JP6640086B2 (enExample) |
| CN (1) | CN105764334B (enExample) |
| AU (2) | AU2014306778B2 (enExample) |
| CA (1) | CA2921187A1 (enExample) |
| IL (1) | IL244093B (enExample) |
| TW (1) | TWI659210B (enExample) |
| WO (1) | WO2015023694A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11931347B2 (en) * | 2015-09-23 | 2024-03-19 | Minerva Biotechnologies Corporation | Method of screening for agents for differentiating stem cells |
| EP3600451B1 (en) * | 2017-03-29 | 2025-12-24 | Minerva Biotechnologies Corporation | Agents for differentiating stem cells and treating cancer |
| CN108434452A (zh) * | 2018-03-13 | 2018-08-24 | 安徽瀚海博兴生物技术有限公司 | 一种将pd-1抗体和jmjd6联合用于制备抗癌药物的应用 |
| CA3183682A1 (en) | 2020-06-26 | 2021-12-30 | Minerva Biotechnologies Corporation | Anti-nme antibody and method of treating cancer or cancer metastasis |
| CN119317447A (zh) | 2022-04-12 | 2025-01-14 | 米纳瓦生物技术公司 | 抗可变muc1*抗体及其用途 |
| WO2025049494A1 (en) | 2023-08-29 | 2025-03-06 | Minerva Biotechnologies Corporation | Bacterial nme7 orthologs and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8562988B2 (en) * | 2005-10-19 | 2013-10-22 | Ibc Pharmaceuticals, Inc. | Strategies for improved cancer vaccines |
| CA2656548A1 (en) * | 2005-06-30 | 2007-01-11 | Whitehead Institute | Progenitor cells and uses thereof |
| WO2007145901A1 (en) * | 2006-06-06 | 2007-12-21 | University Of Tennessee Research Foundation | Compositions enriched in neoplastic stem cells and methods comprising same |
| CA2675521C (en) * | 2007-01-22 | 2016-04-26 | Raven Biotechnologies | Human cancer stem cells |
| CN102272290B (zh) * | 2008-10-09 | 2018-08-14 | 米纳瓦生物技术公司 | 用于在细胞中诱导多能性的方法 |
| EP2686418A4 (en) * | 2011-03-17 | 2015-04-22 | Minerva Biotechnologies Corp | METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS |
| EP2719759A4 (en) * | 2011-05-27 | 2014-12-24 | Public Univ Corp Yokohama City | METHOD OF MANUFACTURING ARTIFICIAL CANCER STRAIN CELLS AND INDUCED DIFFERENTIATION METHOD THEREFOR |
| CN109456932A (zh) * | 2011-10-17 | 2019-03-12 | 米纳瓦生物技术公司 | 用于干细胞增殖和诱导的培养基 |
| WO2013081188A1 (ja) * | 2011-11-30 | 2013-06-06 | 独立行政法人国立がん研究センター | 誘導悪性幹細胞 |
| WO2014018679A2 (en) * | 2012-07-24 | 2014-01-30 | Minerva Biotechnologies Corporation | Nme variant species expression and suppression |
| CA2901893C (en) * | 2013-02-20 | 2022-08-30 | Minerva Biotechnologies Corporation | Nme inhibitors and methods of using nme inhibitors |
-
2014
- 2014-08-12 AU AU2014306778A patent/AU2014306778B2/en active Active
- 2014-08-12 WO PCT/US2014/050773 patent/WO2015023694A2/en not_active Ceased
- 2014-08-12 CN CN201480055352.5A patent/CN105764334B/zh active Active
- 2014-08-12 JP JP2016534802A patent/JP6640086B2/ja active Active
- 2014-08-12 CA CA2921187A patent/CA2921187A1/en active Pending
- 2014-08-12 TW TW103127591A patent/TWI659210B/zh active
- 2014-08-12 EP EP23160947.0A patent/EP4233536B1/en active Active
- 2014-08-12 EP EP14835875.7A patent/EP3038462B1/en active Active
-
2016
- 2016-02-11 IL IL244093A patent/IL244093B/en unknown
-
2019
- 2019-08-23 JP JP2019152467A patent/JP6902577B2/ja active Active
-
2021
- 2021-01-22 AU AU2021200429A patent/AU2021200429C1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cianflone et al. | Targeting cardiac stem cell senescence to treat cardiac aging and disease | |
| Hinrichsen et al. | Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis | |
| JP2016527901A5 (enExample) | ||
| EP4281567A1 (en) | Reprogrammable tnpb polypeptides and use thereof | |
| Magenta et al. | Oxidative stress and microRNAs in vascular diseases | |
| AU2021364399A9 (en) | Reprogrammable iscb nucleases and uses thereof | |
| JP2019047818A5 (enExample) | ||
| MY185961A (en) | Methods and compositions for gene editing in hematopoietic stem cells | |
| AR102888A1 (es) | Animales no humanos que tienen un gen humanizado de agrupamiento de diferenciación 47 | |
| Kanarek et al. | Critical role for IL-1β in DNA damage-induced mucositis | |
| HRP20200613T1 (hr) | Neljudske životinje koje imaju humanizirani gen 1 za programiranu staničnu smrt | |
| JP7288853B2 (ja) | ゲノムネットワークを構築するための方法およびその使用 | |
| CY1119283T1 (el) | Γενετικα τροποποιημενοι ποντικοι εκφραζοντες χιμαιρικα μορια μειζονος συμπλεγματος ιστοσυμβατοτητας (mhc) ii | |
| BR112016006261A2 (pt) | camundongo, célula ou tecido de camundongo isolado, e, métodos para produzir um camundongo, para enxertar células humanas em um camundongo e para avaliar a eficácia terapêutica de uma droga que alveja células humanas | |
| HK1216299A1 (zh) | 表徵醋酸格拉替雷相关的药品 | |
| EP4437094A1 (en) | Reprogrammable iscb nucleases and uses thereof | |
| WO2016007570A3 (en) | Engineered invariant natural killer t (inkt) cells and methods of making and using thereof | |
| JP2020520680A5 (enExample) | ||
| EP4448744A2 (en) | Reprogrammable fanzor polynucleotides and uses thereof | |
| Holbrook et al. | Expanding the spectrum of pancreatic cancers responsive to vesicular stomatitis virus-based oncolytic virotherapy: challenges and solutions | |
| MacLean II et al. | The RHOX homeodomain proteins regulate the expression of insulin and other metabolic regulators in the testis | |
| Patrushev et al. | Mutations in mitochondrial DNA and approaches for their correction | |
| CN116583599A (zh) | 可重编程IscB核酸酶及其用途 | |
| Pesce et al. | Endothelial and cardiac progenitors: boosting, conditioning and (re) programming for cardiovascular repair | |
| CN117616126A (zh) | 可重新编程的tnpb多肽及其用途 |